Neutral
EyePoint Highlights DURAVYU Phase 3 Progress and Cash Runway
EyePoint Pharmaceuticals provided an update on its DURAVYU Phase 3 trials for wet AMD and DME, confirming full enrollment for wet AMD trials with data...
EYPT
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest EYPT News
Neutral
Research EYPT on:
Ad Space